Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model
Version 2 2024-06-04, 00:19
Version 1 2022-01-06, 15:21
journal contribution
posted on 2024-06-04, 00:19 authored by K Zhou, X Huo, R Nguyen, SDW Bae, S Han, Z Zhang, Wei DuanWei Duan, L Yuen, V Lam, J George, L QiaoAptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model
History
Journal
Journal of Controlled ReleaseVolume
341Pagination
341-350Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
0168-3659eISSN
1873-4995Language
EnglishPublication classification
C1 Refereed article in a scholarly journalPublisher
ElsevierUsage metrics
Categories
Keywords
ACIDAFFINITYANTIBODYAptamerCANCER STEM-CELLScancer stem-like cells (CSCs)CELL ADHESION MOLECULEChemistryChemistry, MultidisciplinaryDoxEpCAMEPCAMEXPRESSIONHCCLife Sciences & BiomedicineMARKEROrganoidsPharmacology & PharmacyPhysical SciencesScience & TechnologyTHERAPEUTICSTUMOR PENETRATION3214 Pharmacology and pharmaceutical sciences4003 Biomedical engineering
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC